
Core EM - Emergency Medicine Podcast
Core EMAudio
- Format:
- Podcast
- New episodes:
- Monthly
- Typical length:
- about 15 minutes
- Latest episode:
About this show
Core EM Emergency Medicine Podcast
Covers: emergency medicine, medical education, toxicology, infectious diseases, critical care, cardiology, endocrinology, pediatric emergency medicine
Show details and episodes come from the publisher's public feed at coreem.net. Last updated . Names, artwork and text belong to their publishers.
Recently on this show
Summary of recent episodes, drawn from the publisher's feed.
Core EM is an emergency medicine podcast focused on conditions seen in the emergency department. Recent episodes cover DRESS drug reactions, iron poisoning, tickborne illnesses, acute diarrhea, superwarfarin toxicity, and kidney stones.
Cosmos
Similar in subject
- EMCrit FOAM Feed
Both cover: critical care, toxicology, emergency medicine - Critical Care Scenarios
Both cover: critical care, toxicology, medical education - The Cribsiders
Both cover: pediatric emergency medicine, medical education
Similar shows
Explore more
Episodes
Episode 230: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
· 10 min
https://coreem.net/podcast/episode-230-dress/ DRESS in the ED: Diagnosing this delayed drug reaction behind rash and shock & how to manage. Hosts: Nir Lavi-Romer, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/DRESS.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/DRESS.mp3) Leave a Comment (https://coreem.net/podcast/episode-230-dress/#comments) Tags: Allergy + Immunology (https://coreem.net/tag/allergy-immunology/), Critical Care (https://coreem.net/tag/critical-care/), Dermatology (https://coreem.net/tag/dermatology/), DRESS (https://coreem.net/tag/dress/), Rash (https://coreem.net/tag/rash/) Podcast Video Show Notes Core EM Modular CME Course Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights: - Credit: 12.5 AMA PRA Category 1 Credits™ - Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics. - Cost: - Free for NYU Learners - $250 for Non-NYU Learners Click Here to Register and Begin Module 1 (https://www.highmarksce.com/nyumc/Planners/viewActivity?style=2&preview=true&plannerID=3560#CourseDetails) DRESS vs SJS/TEN vs Anaphylaxis at a Glance DRESS SJS/TEN Anaphylaxis Onset after drug ~2–8 wks; hrs–days on re-exposure ~1–3 wks Min–hrs Skin Diffuse, infiltrated erythema; blisters rare Dusky lesions → blisters, sloughing Urticaria, flushing Nikolsky Neg Pos Neg Mucosa Mild, if any Severe, hemorrhagic Angioedema Big clues Facial edema, lymphadenopathy, eos, organ injury Epidermal detachment Wheeze, ↓BP, GI sx Response to epi None None Expected Background - Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): drug exposure → rash + systemic involvement (liver, kidneys, lungs, heart, pancreas) - Systemic dz is what makes pts critically ill → think ICU. Mortality up to ~10% in retrospective series; 1.7% in a prospective multinational registry (SEAIC 2020 (https://doi.org/10.18176/jiaci.0480)) - Eosinophilia not universal → also called drug-induced hypersensitivity syndrome (DIHS) - Rare, but can’t-miss Pathophysiology - Type IV, T-cell–mediated delayed hypersensitivity; Th2 cytokines (IL-5) recruit eosinophils (SEAIC 2020 (https://doi.org/10.18176/jiaci.0480)) - Not IgE-mediated → don’t expect an anaphylaxis-style response to epi - Exact cause unclear. Two leading contributors: - Genetics: HLA polymorphisms, e.g., HLA-A*31:01 w/ carbamazepine DRESS (CPIC 2018 (https://doi.org/10.1002/cpt.1004)) - Herpesvirus reactivation (HHV-6, HHV-7, EBV, CMV) in up to ~75%; cause vs consequence still unsettled The Culprit Drugs - 200+ drugs implicated; a short list does most of the damage: - Allopurinol, vancomycin, TMP-SMX & other sulfas - Aromatic antiepileptic drugs (AEDs): phenytoin, phenobarbital, carbamazepine, lamotrigine - Less common: NSAIDs, antiretrovirals, ACEi, CCBs, atypical antipsychotics - Latency: classically 2–8 wks after starting the drug; re-exposure → hrs to days (SEAIC 2020 (https://doi.org/10.18176/jiaci.0480)) - Med rec has to look back: SEAIC treats any drug started <6 mo & stopped <14 d before onset as a compatible suspect Clinical Presentation - Rash: itchy morbilliform eruption → diffuse, confluent, infiltrated erythema, often >50% BSA; can be tender. Blisters & sloughing rare - Facial edema: classic - Lymphadenopathy (LAD), fever - Mucosa: mild, ~half of pts, usually 1 site (mouth/pharynx) - Organs: liver most common (~75%) & the leading cause of death; kidney (esp. allopurinol), lungs, heart (myocarditis), pancreas (SEAIC 2020 (https://doi.org/10.18176/jiaci.0480)) - Sick end of the spectrum: shock, hypoxemia, AMS, multi-organ failure Diagnosis Clinical Dx - Built on hx (new drug, wks back) + exam. Labs & biopsy support it;…
Not rated yetEpisode 229: Iron Poisoning
· 12 min
https://coreem.net/podcast/episode-229-iron-poisoning/ Iron overdose in the ED: five stages, elemental iron math, decontamination, and deferoxamine. Hosts: Brian Chastain, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Iron_Poisoning.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Iron_Poisoning.mp3) Leave a Comment (https://coreem.net/podcast/episode-229-iron-poisoning/#comments) Tags: Toxicology (https://coreem.net/tag/toxicology/) Podcast Video Show Notes Core EM Modular CME Course Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights: - Credit: 12.5 AMA PRA Category 1 Credits™ - Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics. - Cost: - Free for NYU Learners - $250 for Non-NYU Learners Click Here to Register and Begin Module 1 (https://www.highmarksce.com/nyumc/Planners/viewActivity?style=2&preview=true&plannerID=3560#CourseDetails) Iron Poisoning Stages at a Glance Stage Timing What’s happening 1 · GI 30 min–6 h Direct corrosive GI injury; abd pain, vomiting 2 · Latent 6–24 h GI sx improve; iron redistributing into tissues 3 · Shock / acidosis 6–72 h Profound metabolic acidosis → shock, MSOF 4 · Hepatotoxicity 12–96 h Hepatotoxicity → fulminant liver failure 5 · GI scarring 2–8 wks Gastric outlet obstruction, GI tract scarring The Case - 31M w/ hx depression, anxiety; found minimally responsive at home by family - EMS: HR 67, SpO2 96% on 2 L NC, BP 46/21; withdraws to pain, not opening eyes → 2 L IVF + push-dose epi en route - ED: BP ↑ to 90/61, other VS unchanged; dried vomit on lips/shirt; breathing comfortably, protecting airway - POC VBG: pH 7.24, pCO2 33, pO2 25, HCO3 14, lactate 2.5 - ECG: NSR, otherwise unremarkable → get an ECG in any possible toxic ingestion - Additional 30 mL/kg bolus + norepi gtt - Family arrives → bottle of iron pills under the pt’s bed Pathophysiology - Free iron = multisystem oxidative injury - Primary mechanism: free radical generation + lipid peroxidation → damages cellular and mitochondrial membranes throughout the body - Profound metabolic acidosis via 2 routes: uncoupled oxidative phosphorylation → anaerobic metabolism → lactate; Fe³⁺ reacts w/ water → releases 3 H⁺ → excess acid - Direct mucosal necrosis in the gut (corrosive injury) - Negative inotrope on the myocardium → hypotension, cardiogenic shock in large ingestions Clinical Stages - Classic progression after large ingestions; stages overlap and pts can present anywhere along the timeline - Stage 1, GI (30 min–6 h): direct GI tract injury; abd pain, vomiting. Persistent vomiting = very sensitive indicator of a serious ingestion - Stage 2, latent (6–24 h): GI sx improve, but iron is redistributing into the tissues → ongoing damage - The latent-phase trap: pts look like they’re turning the corner right before they crump. Contrast: pts never symptomatic >6 h after ingestion are unlikely to develop toxicity (AAPCC 2005 (https://doi.org/10.1081/clt-200068842)); GI sx that improve ≠ never symptomatic - Stage 3, shock (6–72 h): tissue iron → profound acidosis → shock, MSOF - Stage 4, hepatotoxicity (12–96 h): hepatotoxicity → fulminant liver failure - Stage 5, GI scarring (2–8 wks): gastric outlet obstruction, GI tract scarring from the initial corrosive injury Diagnosis / Workup Imaging - Emergent plain-film abd XR in any suspected iron ingestion → intact adult iron tabs are radiopaque - Confirms pills still in the stomach/GI tract → helps decide on WBI - Negative XR ≠ no ingestion: chewables, liquid formulations and already-dissolved tabs often don’t show up Serum Iron - Draw 4–6 h post-ingestion for regular formulations, ~8 h for extended release -…
Not rated yetEpisode 228: Tickborne Illnesses
https://coreem.net/podcast/episode-228-tickborne-illnesses/ Tickborne illnesses in the ED: attachment time, the rash, the smear, prophylaxis, & treatment. Hosts: Samantha Nakos, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Tickborne_Illnesses_1_.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Tickborne_Illnesses_1_.mp3) Leave a Comment (https://coreem.net/podcast/episode-228-tickborne-illnesses/#comments) Tags: Babesiosis (https://coreem.net/tag/babesiosis/), Ehrlichiosis (https://coreem.net/tag/ehrlichiosis/), Infectious Diseases (https://coreem.net/tag/infectious-diseases/), Lyme Disease (https://coreem.net/tag/lyme-disease/), Tick-Borne Illnesses (https://coreem.net/tag/tick-borne-illnesses/) Podcast Video Show Notes Core EM Modular CME Course Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights: - Credit: 12.5 AMA PRA Category 1 Credits™ - Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics. - Cost: - Free for NYU Learners - $250 for Non-NYU Learners Click Here to Register and Begin Module 1 (https://www.highmarksce.com/nyumc/Planners/viewActivity?style=2&preview=true&plannerID=3560#CourseDetails) Lyme, Anaplasmosis, Ehrlichiosis & Babesiosis at a Glance Lyme Anaplasmosis Ehrlichiosis Babesiosis Organism B. burgdorferi (spirochete) A. phagocytophilum E. chaffeensis B. microti (protozoan) Vector I. scapularis I. scapularis Lone star tick I. scapularis Attachment time ≥36–48 h Can be <24 h No data Mostly >48 h Key clue EM rash ↓WBC, ↓plt, ↑LFTs ↓WBC, ↓plt, ↑LFTs Hemolysis, ↓plt Smear — Morulae in neutrophils Morulae in monocytes Intra-RBC parasites, Maltese cross Confirm Clinical (EM) Smear, PCR Smear, PCR Smear, PCR Treat Doxy × 10–14 d Doxy × 10 d Doxy until ≥3 d afebrile Atovaquone + azithro × 7–10 d Background - Ixodes scapularis (deer tick) = primary US vector for Lyme, anaplasmosis, and babesiosis; I. pacificus on the West Coast. Ehrlichiosis → lone star tick (Amblyomma americanum), not the deer tick (CDC MMWR 2016 (https://doi.org/10.15585/mmwr.rr6502a1)) - Why attachment time matters: B. burgdorferi lives in the tick midgut → multiplies and migrates to the salivary glands only after feeding starts → built-in delay - Single infected nymph: 0 of ~90 animals infected at 24 h, ~10% by 48 h, ~70% by 72 h (Eisen 2018 (https://doi.org/10.1016/j.ttbdis.2018.01.002)) - Anaplasma can transmit w/in 24 h. Babesia ≈ Lyme, not faster: earliest 36 h, mostly after 48 h. True speedster = Powassan virus (w/in 15 min). Attachment time by hx is often unreliable (IDSA Lyme 2020 (https://doi.org/10.1093/cid/ciaa1215)) - Regional variation: US Lyme = B. burgdorferi; Europe = mostly B. afzelii, B. garinii → different clinical picture. Systemic sx w/ EM more common in the US: ~65% vs ~37% in Europe (IDSA Lyme 2020 (https://doi.org/10.1093/cid/ciaa1215)) Lyme: The Rash and the Serology Erythema Migrans - EM in ~70–80% of infections; appears at the bite site 3–30 d post-bite (avg ~7 d) (CDC (https://www.cdc.gov/lyme/signs-symptoms/index.html)) - Usually not a bull’s-eye → most early EM is uniformly red - Expanding erythematous patch + endemic area = Lyme until proven otherwise Serology - 2-tier: EIA or IFA → IgM/IgG Western blot (or modified 2-tier: 2 EIAs, no blot) - Early localized dz → often seronegative (as few as ~20% positive w/in 1 wk of noticing EM) → EM in an endemic area = clinical dx, per IDSA (IDSA Lyme 2020 (https://doi.org/10.1093/cid/ciaa1215)) The Other Three: Labs and the Smear Babesiosis - Hunt for hemolytic anemia: ↓Hgb, ↑LDH, ↓haptoglobin, reticulocytosis; ↓plt and ↑LFTs common - Smear: intraerythrocytic parasites. Maltese cross (tetrad) =…
Not rated yetEpisode 227: Diarrhea
· 14 min
https://coreem.net/podcast/episode-227-diarrhea/ Acute diarrhea in the ED: stool testing, treatment, and a spotlight on Cyclospora. Hosts: Neya Vishwanath, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Diarrhea.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Diarrhea.mp3) Leave a Comment (https://coreem.net/podcast/episode-227-diarrhea/#comments) Tags: Gastrointestinal (https://coreem.net/tag/gastrointestinal/), Gastrointestinal Diseases (https://coreem.net/tag/gastrointestinal-diseases/) Podcast Video Show Notes Core EM Modular CME Course Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights: - Credit: 12.5 AMA PRA Category 1 Credits™ - Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics. - Cost: - Free for NYU Learners - $250 for Non-NYU Learners Click Here to Register and Begin Module 1 (https://www.highmarksce.com/nyumc/Planners/viewActivity?style=2&preview=true&plannerID=3560#CourseDetails) Framing the Patient - Acute is <2 weeks, persistent is 2–4 weeks, chronic is >30 days. Most acute diarrhea is self-limited and needs only supportive care. - Stool cultures are positive in only 2–6% of unselected patients. Yield rises with >4 stools/day and longer duration. - The ED job is not to name the organism. It is to find volume depletion, rule out the dangerous mimic, and decide who needs testing, antibiotics, or admission. Don’t-Miss Mimics - Diarrhea is a symptom, not a diagnosis. In anyone who looks sick, gastroenteritis is a diagnosis of exclusion. - Abdominal catastrophes: mesenteric ischemia (pain out of proportion, vascular risk factors), early appendicitis, partial obstruction with overflow stool, diverticulitis. - Systemic disease presenting through the gut: sepsis from another source, DKA, adrenal insufficiency. - Fulminant C. diff or toxic megacolon: distension, fever, tachycardia, peritonitis. The diarrhea may actually stop as the colon dilates. - GI bleeding masquerading as dark diarrhea, and in women of childbearing age, ectopic pregnancy. History & Exam - Duration, frequency, and appearance. Watery and high-volume suggests small bowel. Small, painful, frequent stools suggest colon. - Volume status: urine output, dark concentrated urine, dry mucous membranes, orthostatic symptoms. - Exposures: recent foods, travel, sick contacts, occupation (animal or sewage contact), recent antibiotics or hospitalization. - Timing after ingestion: <6 hours suggests a preformed toxin (Staph aureus, Bacillus cereus), 8–16 hours suggests Clostridium perfringens, and >16 hours suggests viral or other bacterial causes. - High-risk hosts: pregnancy → Listeria, cirrhosis → Vibrio, hemochromatosis → Yersinia (both siderophilic). - Exam: volume status plus a real abdominal exam. A soft belly does not end the evaluation. Who Gets Testing - Ask first whether the result will change anything. If the patient is going home on supportive care, a stool study often just generates a callback. - Test when the patient is likely to be admitted or is higher risk: febrile, hypovolemic, elderly (roughly >70), known cardiac disease, immunocompromised, IBD, or pregnant. - Bloodwork is not routine. Send a BMP and CBC for significant hypovolemia, persistent vomiting, bloody stool, or the elderly and comorbid. - Routine cultures cover Salmonella, Campylobacter, Shigella. Ask the lab specifically for Vibrio, Yersinia, Aeromonas, or Listeria. - Know your multiplex GI PCR panel. At many shops it already includes C. diff, so ordering it separately is redundant. One call to your lab settles this. - Bloody stool → send Shiga toxin. Bloody but fecal WBC negative → consider amoebiasis. - Bloody…
Not rated yetEpisode 226: Superwarfarin Toxicity
· 13 min
https://coreem.net/podcast/episode-226-superwarfarin-toxicity/ Superwarfarin toxicity: recognition, reversal, and prolonged vitamin K therapy. Hosts: Mac Josh Reandelar, DO Avir Mitra, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Superwarfarin_Toxicity.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Superwarfarin_Toxicity.mp3) Leave a Comment (https://coreem.net/podcast/episode-226-superwarfarin-toxicity/#comments) Tags: Toxicology (https://coreem.net/tag/toxicology/) Show Notes Toxicology & Pathophysiology - Long-acting vitamin K antagonists (LA-VKAs), developed as potent rodenticides - Examples: brodifacoum, bromadiolone, difenacoum, chlorophacinone - Much more potent + far longer acting than warfarin - MOA: inhibits VKORC1 → ↓ vitamin K recycling → impaired γ-carboxylation - ↓ factors II, VII, IX, X + proteins C/S - Highly lipophilic → extensive tissue/fat sequestration + slow redistribution - Effect can persist weeks-months; occasionally much longer - Not dialyzable - Exposure: large acute ingestion OR repeated low-dose exposure - Source may be unclear, concealed, or initially unknown Presentation - Often delayed + insidious - Severe coagulopathy may precede obvious bleeding - Early: epistaxis, gingival bleeding, bruising/ecchymoses, hematuria - Classic clue: well-appearing pt + extraordinarily abnormal coagulation studies - Severe bleeding: RP hemorrhage, ICH, spinal hemorrhage, tamponade, major GI/GU bleeding - RP bleed → flank/back pain ± CVA tenderness Labs & Diagnosis - PT/INR: profoundly elevated, sometimes beyond assay range - aPTT: may also be markedly prolonged with severe factor depletion - CBC/plts: often initially preserved unless major blood loss/other process - LFTs: often relatively normal - Profound INR + no warfarin + preserved liver function → think superwarfarin - CT based on bleeding site; CT A/P for suspected RP hemorrhage - Confirm: specialized serum/blood testing for long-acting anticoagulants, typically chromatography/mass spec - Do NOT delay resuscitation/treatment for confirmatory testing Elevated INR: Differential - Superwarfarin exposure - Warfarin toxicity - Severe vitamin K deficiency: malnutrition, malabsorption, prolonged abx - Liver failure/cirrhosis - DIC - Acquired factor deficiency/inhibitor Helpful discriminators - Liver dz → abnormal hepatic profile/clinical context - DIC → ↓ plts, ↓ fibrinogen, ↑ D-dimer - No warfarin + massive INR + relatively normal LFTs/plts → superwarfarin rises on the differential ED Management Major/Life-Threatening Bleeding - Goal: replace factors NOW + restore endogenous synthesis - 4F-PCC = preferred factor replacement - Fast, predictable correction - Small volume - No thawing/type matching - FFP if PCC unavailable - Slower + large volume/TACO risk - Give IV vitamin K concurrently - PCC = immediate bridge; vitamin K = sustained factor synthesis - Recheck INR + clinical bleeding response - Repeat PCC generally not routine; reassess before redosing No Major Bleeding, Critical INR - Vitamin K is primary therapy - High-dose PO vitamin K often preferred when clinically stable - Avoid unnecessary PCC/FFP if no major bleeding - Serial INR monitoring essential Poison Control - Call early - Helps with: - Confirmatory testing - Vitamin K dosing - Duration of therapy - Monitoring/taper strategy - Outpatient planning The Long Game - This is NOT standard warfarin toxicity - Vitamin K requirements may persist for months - Discharge only when bleeding controlled + clinically stable on oral regimen - Close serial INR follow-up mandatory - Slowly taper vitamin K under laboratory guidance - Stopping too early → rebound INR elevation + recurrent bleeding Take Home Points - Massive unexplained INR + relatively normal liver function → think superwarfarin - Major bleeding → 4F-PCC + IV vitamin K - Expect prolonged vitamin K therapy + meticulous INR…
Not rated yetEpisode 225: Group A Strep
https://coreem.net/podcast/episode-225-group-a-strep/ Group A strep in the pediatric ED: from strep throat to invasive disease and toxic shock. Host: Ellen Duncan, MD, PhD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Group_A_Strep.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Group_A_Strep.mp3) Leave a Comment (https://coreem.net/podcast/episode-225-group-a-strep/#comments) Tags: Infectious Diseases (https://coreem.net/tag/infectious-diseases/), Pediatrics (https://coreem.net/tag/pediatrics/) Show Notes Background - Group A strep = Streptococcus pyogenes — gram-positive organism that colonizes the pharynx, but also the perianal and genital mucosa (worth remembering when the source isn’t the throat). - Extremely common. The episode cites an estimated ~289 million cases/yr of strep pharyngitis in children 5–14 (NIH). For a U.S.-specific, verifiable anchor: the CDC (https://www.cdc.gov/group-a-strep/php/surveillance/index.html) estimates strep throat drives ~5.2 million outpatient visits/yr in people <65. - No true beta-lactam resistance. GAS remains uniformly susceptible to penicillin and amoxicillin. Note this is not true for macrolides/clindamycin — roughly 1 in 3 invasive isolates are now erythromycin/clindamycin resistant. Pathophysiology — the throughline - Exotoxins (superantigens) tie the whole spectrum together — they drive scarlet fever, streptococcal toxic shock syndrome (STSS), and are implicated in the Kawasaki overlap discussed below. - The organism is the same from a sore throat to a life-threat; what changes is host response and toxin burden. Clinical Presentation - Core findings: tonsillar inflammation/exudate, tender anterior cervical lymphadenopathy, fever. - Classic strep tells to hunt for: - Palatal petechiae - Strawberry tongue - Perioral pallor - Scarlet fever — fine, sandpapery rash, typically starts on the trunk and spreads outward; later desquamation of the fingers and toes. - Extrapharyngeal clues: kids commonly present with abdominal pain or headache even when the throat looks unimpressive. Low threshold to test with fever + abd pain or fever + headache. Diagnosis / Workup Centor / Modified (McIsaac) Score - Centor Score (Modified/McIsaac) — MDCalc (https://www.mdcalc.com/calc/104/centor-score-modified-mcisaac-strep-pharyngitis) - One point each: fever, tonsillar exudates, tender anterior cervical lymphadenopathy, absence of cough. The Modified (McIsaac) version adds age. - Developed and validated in adults (≥16). It is not reliable in young children — don’t lean on it in peds the way you would in an adult. - For reference, McIsaac culture-positive probabilities: ~2.5% (0 criteria), 6.5% (1), 15% (2), 32% (3), 56% (4). Testing - Rapid PCR — high sensitivity and specificity; increasingly the front-line test. - Rapid antigen detection test (RADT) — highly specific but less sensitive. Per IDSA (https://academic.oup.com/cid/article/55/10/e86/321183), a negative RADT in a child/adolescent should be backed up with a throat culture (culture is the more sensitive gold standard). Backup culture is not required in adults. Who not to test - Generally don’t test/treat children <3 — acute rheumatic fever is rare in this group. - Exception: the symptomatic young child with a close contact recently diagnosed with strep. Management - First-line: amoxicillin 50 mg/kg once daily, max 1 g/dose. GAS stays beta-lactam susceptible (penicillin and amoxicillin remain treatments of choice per IDSA 2012 (https://www.idsociety.org/practice-guideline/streptococcal-pharyngitis/)). - IM penicillin G / benzathine (bicillin) for kids who can’t tolerate oral meds — one shot, done. - Return to school: after one full day of treatment (~12–24 h), provided afebrile and feeling well. - Contact prophylaxis: - Pharyngitis — routine prophylaxis of asymptomatic contacts is not standard; consider it for households with recurrent infection or…
Not rated yetEpisode 224: Kidney Stones
https://coreem.net/podcast/episode-224-kidney-stones/ A guide to diagnosing, imaging, and managing acute renal colic and nephrolithiasis in the ED. Hosts: Brian Gilberti, MD Avir Mitra, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Nephrolithiasis.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Nephrolithiasis.mp3) Leave a Comment (https://coreem.net/podcast/episode-224-kidney-stones/#comments) Tags: Kidney Stones (https://coreem.net/tag/kidney-stones/), Urology (https://coreem.net/tag/urology/) Show Notes 1. CLINICAL CORE & PHYSIOLOGIC FRAMEWORK - Epidemiologic Risk Profiles - Lifetime incidence parameters hover around 1 in 11, presenting with a prominent male sex skew. - Peak demographic manifestation concentrated within the 30–60 age band. - High-yield temporal parameter: 50% recurrence vector within a 5-year post-initial-insult window. - Mineralogical Composition Vectors - Calcium oxalate crystals represent the predominant structural matrix. - Struvite configurations (magnesium ammonium phosphate matrix) account for 1–2% of cohorts. - Struvite stones function explicitly as infection-driven configurations secondary to upper tract proliferation; higher distribution index noted in female cohorts. - Etiological & Modifiable Relational Dynamics - Profound systemic dehydration or low baseline fluid throughput states. - High-sodium diet structures and heavy animal-protein consumption loads. - Positive genetic/familial history variables. - Relative risk modulation: Each variable independently operates to expand baseline risk by a factor of 2x to 3x. - Pathophysiologic Symptom Complexes - Acute, sudden-onset, maximum-intensity (10/10) unilateral flank pain. - Classic structural radiation vector tracking downward toward the ipsilateral groin/genitourinary dermatomes. - Distinctive behavioral marker: Renal colic pacing/writhing behavior with zero antalgic position availability. - Concomitant autonomic triggers: Nausea and emesis manifest in 50% of acute presentations. - Physical Exam Discordance Metrics - Severe subjective distress contrasted with a characteristically soft, completely non-tender abdominal palpation exam. - CVA tenderness is completely variable and lacks reliable negative predictive value. - Atypical Presentation Classifications - Vague, poorly localized abdominal pain presentations occurring in up to 20% of active cases. - Isolated lower urinary tract irritative signs including acute frequency or severe urgency. - Incidental & Asymptomatic Dynamics - Silent intrarenal or ureteral stones found incidentally. - Longitudinal tracking demonstrates up to 33.3% of initially asymptomatic cohorts convert to fully symptomatic renal colic within a multi-year tracking window. 2. EXCLUSION DIAGNOSES & CRITICAL PATHWAY RED FLAGS - Vascular Mimics: AAA rupture/expansion. This is a mandatory exclusion pathway in elderly cohorts presenting with acute flank or back pain. Physical tracking requires active exploration for an expansile, pulsatile abdominal mass. - Gynecologic Emergencies: Ruptured ectopic pregnancy. Demands universal screening protocols via rapid beta-hCG testing in all female patients of childbearing potential presenting with lower abdominal/pelvic localization. - Infectious Upper Tract Decompensation: Acute uncomplicated pyelonephritis. Differentiated via persistent high spikes, high fevers, systemic shaking chills, and profound pyuria. - Genitourinary Structural Crises: Acute testicular torsion. Mandates a thorough, explicit scrotal/testicular structural exam if the flank pain radiates into the scrotum. - Gastrointestinal and Adnexal Torsional Confounds: Acute appendicitis variants, acute mesenteric/bowel ischemia, and ovarian torsion syndromes. 3. LABORATORY TESTING & PHYSIOLOGIC EVALUATION - Urinalysis Interpretation Nuances - Microscopic or gross hematuria presents in approximately 66% to 90% of acute cases. - Critical…
Not rated yetEpisode 223: Thyroid Storm
· 9 min
https://coreem.net/podcast/episode-223-thyroid-storm/ Diagnosis, workup, and the four-step treatment protocol for thyroid storm. Hosts: Annaliese Elam, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Thyroid_Storm.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Thyroid_Storm.mp3) Leave a Comment (https://coreem.net/podcast/episode-223-thyroid-storm/#comments) Tags: Critica Care (https://coreem.net/tag/critica-care/), Endocrine (https://coreem.net/tag/endocrine/), Thyroid Storm (https://coreem.net/tag/thyroid-storm/) Show Notes I. Pathophysiology & Diagnosis Definition: Life-threatening hypermetabolic state resulting from decompensated thyrotoxicosis. Hormonal Profile: Absolute levels of total T₄/T₃ often mirror uncomplicated thyrotoxicosis; storm is driven by rapid rate of rise, increased catecholamine sensitivity, or increased free T₄/T₃ concentrations. Clinical Presentation: - Hyperpyrexia (e.g., 104.2°F) - Tachycardia/Arrhythmias (e.g., 155 bpm) - Altered Mentation: Agitation, delirium, or psychosis; often the primary differentiator between “storm” and “compensated” hyperthyroidism - Warm, moist skin Precipitating Events: - Infection, trauma, or surgery - Parturition - Abrupt cessation of antithyroid medications Burch-Wartofsky Point Scale (BWPS) (https://www.mdcalc.com/calc/3816/burch-wartofsky-point-scale-bwps-thyrotoxicosis): - ≥ 45: Highly suggestive of Thyroid Storm - 25–44: Suggestive of impending storm - < 25: Storm unlikely - Note: High sensitivity but low specificity; can be skewed by unrelated febrile illness. II. Laboratory & Ancillary Findings Thyroid Panel: Characteristically low TSH with elevated free T₄ and T₃. Metabolic Abnormalities: - Mild hyperglycemia (catecholamine-induced insulin inhibition) - Mild hypercalcemia - Elevated LFTs and leukocytosis Cardiovascular: EKG may show sinus tachycardia or atrial fibrillation with rapid ventricular response. III. Management: The Four-Step Blocking Strategy - Step 1: Sympathetic Blockade (Beta Blockers) - Agent of Choice: Propranolol - Mechanism: Non-selective blockade; in high doses, inhibits peripheral conversion of T₄ to T₃. - Dosing: - PO: 60–80 mg every 4–6 hours - IV: 0.5–1 mg over 10 minutes - Critical Pitfall: Avoid in patients with acute decompensated heart failure with systolic dysfunction; risk of cardiovascular collapse. - Step 2: Inhibition of Hormone Synthesis (Thionamides) - Agent of Choice: Propylthiouracil (PTU) preferred over Methimazole in life-threatening storm. - Mechanism: Blocks synthesis of new hormone and inhibits peripheral T₄-to-T₃ conversion (decreases T₃ by ~45% in 24 hours). - Dosing: 200–250 mg PO every 4 hours - Step 3: Inhibition of Hormone Release (Iodine) - Agents: Potassium iodide (SSKI) or Lugol’s solution - Critical Timing: Must wait at least 60 minutes AFTER thionamide administration. - Rationale: Immediate iodine administration provides substrate for new hormone synthesis (Wolff-Chaikoff effect bypass), potentially worsening thyrotoxicosis. - Step 4: Inhibition of Peripheral Conversion & Adrenal Support - Agent: Glucocorticoids (Hydrocortisone) - Mechanism: Inhibits peripheral T₄ to T₃ conversion and treats potential relative adrenal insufficiency. - Dosing: 300 mg IV loading dose, followed by 100 mg IV every 8 hours IV. Supportive Care & Avoidance Measures Hyperpyrexia Management: - Acetaminophen is the standard of care - Avoid Aspirin: Salicylates displace thyroid hormone from thyroid-binding globulin (TBG), increasing free T₄/T₃ levels Volume Resuscitation: - Aggressive IV fluids; patients are often profoundly dehydrated - May require 3–5 liters of isotonic crystalloid per 24 hours Take Home Points I. Diagnostic Essentials - Clinical Diagnosis: Based on hyperpyrexia, cardiovascular dysfunction, and altered mentation. - Key Differentiator: Altered mentation (agitation, delirium, psychosis) is often the…
Not rated yetEpisode 222: Local Anesthetic Systemic Toxicity (LAST)
https://coreem.net/podcast/episode-222-local-anesthetic-systemic-toxicity-last/ We discuss this ominous complication of providing local anesthesia. Hosts: Elaine Jonas, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/LAST.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/LAST.mp3) Leave a Comment (https://coreem.net/podcast/episode-222-local-anesthetic-systemic-toxicity-last/#comments) Tags: Critical Care (https://coreem.net/tag/critical-care/), Toxicology (https://coreem.net/tag/toxicology/) Show Notes I. Pathophysiology & Mechanisms - Definition: Systemic toxicity secondary to local anesthetic (LA) via accidental intravascular injection or excessive systemic absorption. - Threshold: Occurs when plasma concentration exceeds the safety threshold for cardiac and neural tissue. - Agent Profile: Bupivacaine (High Risk) - Highly lipophilic with high protein binding. - “Fast-on, Slow-off” Kinetics: Strong Na+ channel binding with extremely slow dissociation during diastole. - Myocardial Depression: Direct inhibition of Ca2+ release from the sarcoplasmic reticulum, impairing contractility. - Low CC:CNS Ratio: The dose required for cardiac collapse is very close to the dose that triggers seizures (narrow safety margin). - Contributing Factors: - Acidosis/Hypercapnia: Increases the fraction of free drug and promotes ion trapping in the brain/heart; shifts the LA-binding curve toward higher toxicity. - Hypoxemia: Exacerbates myocardial depression and lowers seizure threshold. II. Risk Assessment & Prevention Patient-Specific Risk Factors - Extremes of Age: Neonates (low α-1-acid glycoprotein) and elderly (reduced clearance). - Body Composition: Low muscle mass/frailty (decreased volume of distribution). - Organ Dysfunction: - Hepatic: Reduced metabolism of amide LAs. - Renal: Accumulation of metabolites; risk of metabolic acidosis lowering seizure threshold. - Cardiac: Reduced cardiac output slows hepatic delivery/clearance; heart failure patients are more sensitive to Na+ channel blockade. - Pregnancy: Increased sensitivity to cardiotoxicity. Procedural Risk Factors - Vascularity of Site (Highest to Lowest Risk): - Intercostal blocks (highest absorption rate). - Caudal/Epidural. - Interfascial plane blocks (e.g., TAP block). - Psoas compartment/Sciatic. - Brachial plexus. - Technique: Large volume infiltration, lack of ultrasound, lack of incremental injection. Prevention Mandates - Weight-Based Dosing: - Lidocaine (Plain): Max 4.5 mg/kg. - Lidocaine (with Epi): Max 7 mg/kg. - Bupivacaine: Max 2.5–3 mg/kg. - Incremental Injection: 3–5 mL aliquots with frequent aspiration. - Intravascular Marker: Use Epinephrine (1:200,000) to detect accidental IV placement (HR increase >10 bpmor SBP increase >15 mmHg). III. Clinical Presentation Neurologic Phase (Early to Late) - Subjective: Metallic taste, tinnitus, circumoral numbness/tingling. - Objective: Visual disturbances, agitation, confusion, tremors. - Critical: Generalized tonic-clonic seizures, rapid progression to CNS depression, coma, and apnea. - Note: Early phases are often masked in patients receiving midazolam or propofol. Cardiovascular Phase - Initial: Hypertension and tachycardia (if epi used) or transient stimulatory phase. - Conduction Defects: PR prolongation, QRS widening (classic sign), bundle branch blocks. - Dysrhythmias: Bradycardia (most common), VT/VF, PEA, asystole. - Contractility: Profound, refractory hypotension and cardiogenic shock. IV. Immediate Management Algorithm Goal: Prevent hypoxia/acidosis and sequester the toxin. 1. Initial Actions - Stop Injection: Immediately halt all LA administration. - Call for Help: Specify “LAST Protocol” and “Intralipid Kit.” - Airway Management: - 100% O2. - Hyperventilate slightly if needed to counter respiratory acidosis. - Low threshold for intubation (hypoxia/acidosis rapidly worsen LAST). 2. Seizure…
Not rated yetEpisode 221: High-Output Heart Failure
https://coreem.net/podcast/episode-221-high-output-heart-failure/ We discuss the diagnosis and treatment of one of EM's paradoxes: High-Output Heart Failure. Hosts: Nicolas Gonzalez, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/HOHF.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/HOHF.mp3) Leave a Comment (https://coreem.net/podcast/episode-221-high-output-heart-failure/#comments) Tags: Cardiology (https://coreem.net/tag/cardiology/) Show Notes Core EM Modular CME Course Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights: - Credit: 12.5 AMA PRA Category 1 Credits™ - Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics. - Cost: - Free for NYU Learners - $250 for Non-NYU Learners Click Here to Register and Begin Module 1 (https://www.highmarksce.com/nyumc/Planners/viewActivity?style=2&preview=true&plannerID=3560#CourseDetails) 1. Core Definition & Hemodynamic Profile - Clinical Paradox: Congestive symptoms (pulmonary edema, JVD, peripheral edema) in the setting of a hyperdynamic, supranormal cardiac function. - Hemodynamic Criteria: - Cardiac Index (CI): >4.0 L/min/m2. - Cardiac Output (CO): >8 L/min. - Systemic Vascular Resistance (SVR): Pathologically low (vasodilated or shunted state). - The “Warm” Phenotype: Unlike standard HFrEF/HFpEF (often “Cold and Wet”), HOHF presents as “Warm and Wet” due to low SVR and bounding pulses. 2. Pathophysiology: The Hemodynamic Paradox - Primary Insult: Decreased SVR (either via peripheral vasodilation or arteriovenous shunting). - Effective Arterial Blood Volume: Paradoxically low despite high total CO. - Neurohormonal Cascade: - Activation of Renin-Angiotensin-Aldosterone System (RAAS). - Increased Sympathetic Nervous System tone. - Increased Antidiuretic Hormone (ADH) secretion. - Resultant State: Avid renal salt and water retention leading to massive plasma volume expansion. - Cardiac Response: Chronic volume overload → eccentric remodeling → chamber dilation → eventual secondary myocardial failure/dilated cardiomyopathy. 3. Differential Diagnosis: Etiological “Buckets” Category A: Increased Metabolic Demand (Systemic) - Hyperthyroidism/Thyrotoxicosis: - Direct T3 effects: increased chronotropy/inotropy. - Indirect effects: metabolic byproduct accumulation causing peripheral vasodilation. - Myeloproliferative Disorders: - High cell turnover and increased oxygen consumption drive compensatory CO increase. - Sepsis (Hyperdynamic Phase): - Cytokine-mediated global vasodilation. - Note: Often transient; may transition to sepsis-induced myocardial depression. Category B: Peripheral Vascular Effects (Shunting/Vasodilation) - Arteriovenous Fistulas (AVF) / Malformations (AVM): - Most Common Cause: Iatrogenic AVF for Hemodialysis (ESRD population). - Bypasses high-resistance capillary beds, dumping arterial blood directly into venous circulation. - Chronic Liver Disease (Cirrhosis): - Formation of “spider angiomata” and internal AV shunts. - Impaired clearance of endogenous vasodilators (e.g., Nitric Oxide). - Thiamine Deficiency (Wet Beriberi): - Accumulation of pyruvate/lactate → systemic vasodilation. - Histopathology: Vacuolation, myofiber hypertrophy, and interstitial edema. - Chronic Lung Disease: - Hypoxia/Hypercapnia-driven systemic vasodilation. - Concomitant pulmonary HTN (RV remodeling) but preserved/high LV output. - Others: Paget’s disease of bone (extensive micro-shunting), Carcinoid syndrome, Mitochondrial diseases, Acromegaly, Erythroderma. 4. Special Focus: Hemodialysis Access-Induced HOHF Physiologic Phases of AVF Creation: - Acute Phase: - Immediate ↓ SVR. - ↑ Stroke volume and Heart…
Not rated yetEpisode 220: Post-ROSC Care
https://coreem.net/podcast/episode-220-post-rosc-care/ We explore how to refine and optimize care in the vital minutes following ROSC. Hosts: Jonathan Elmer, MD, MS Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Post-ROSC_care.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Post-ROSC_care.mp3) Leave a Comment (https://coreem.net/podcast/episode-220-post-rosc-care/#comments) Show Notes Core EM Modular CME Course Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights: - Credit: 12.5 AMA PRA Category 1 Credits™ - Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics. - Cost: - Free for NYU Learners - $250 for Non-NYU Learners Click Here to Register and Begin Module 1 (https://www.highmarksce.com/nyumc/Planners/viewActivity?style=2&preview=true&plannerID=3560#CourseDetails) I. Phase 1: Stabilization (Minutes 0–10) The “Rearrest” Window & Pathophysiology - High-Risk Period: Rearrest rates reach 30% within the first minutes post-ROSC. - Shock Incidence: Two-thirds of patients develop profound hypotension/shock as initial resuscitative efforts subside. - Catecholamine Washout: Super-physiologic “code-dose” epinephrine (1mg IV) typically wears off within ~3 minutes post-ROSC, leading to predictable hemodynamic collapse. - Secondary Injuries: Evaluate for “CPR-induced trauma” (blunt thoracic trauma, rib fractures, pneumothorax, liver/splenic lacerations). Immediate Resuscitative Actions - Vascular Access: - Transition rapidly from IO to reliable IV access within 1–2 minutes. - Prioritize Intraosseous (IO) placement within 5 minutes if IV attempts fail; intra-arrest data suggests no significant difference in early outcomes. - Vasoactive “Bridge”: - Maintain a “bolus-dose” pressor at the bedside for immediate push-dose titration. - Options: Phenylephrine, dilute Epinephrine, or dilute Norepinephrine (titrated to effect rather than rigid dosing). - Physician-Specific Task: Arterial Line: - Goal: Placement within 5 minutes of ROSC. - Preferred Site: Femoral (by landmarks/blind if necessary) for speed; should be a <2-minute procedure. - Utility: Immediate detection of rearrest and beat-to-beat titration of vasopressors. II. Phase 2: Diagnostic Workup (Minutes 10–40) Etiology Epidemiology - ACS Shift: Acute Coronary Syndrome (ACS) is the cause in only 6–10% of resuscitated survivors (lower than historical estimates). - Common Etiologies: - Respiratory: COPD, pneumonia, mucus plugging. - Cardiac: Arrhythmia (cardiomyopathy/scar), RV failure (PE), or LV failure. - Neurological: Intracranial hemorrhage (SAH/ICH), status epilepticus (4–5%). - Metabolic: Dialysis-related disarray/hyperkalemia. - Toxicology: Overdose accounts for ~10% of cases in urban centers. The “Broad Net” Strategy - “Rainbow Labs”: Comprehensive panel including toxicology and serial biomarkers. - Pan-Scan Protocol: - Components: CT/CTA Head/Neck, Contrast CT Chest/Abdomen/Pelvis. - Diagnostic Yield: 50% for clinically significant findings (causes or consequences of arrest). - Contrast Risk: Negligible (1–2% increase in AKI risk) compared to the high diagnostic utility. - Avoid Anchoring: Do not assume ischemic EKG changes are the cause; they are frequently a consequence of the global arrest-induced ischemia. III. Hemodynamic & Respiratory Targets Mean Arterial Pressure (MAP) - Autoregulation Shift: In acute brain injury/post-arrest, the lower limit of cerebral autoregulation shifts right, often requiring MAPs of 110–120 mmHg for adequate perfusion. - Clinical Target: Aim for MAP >80 mmHg. - The BOX Trial Nuance: While the BOX trial showed no difference between MAP 63 vs. 77, its cohort (Denmark) had…
Not rated yetEpisode 219: Meningitis 2.0
https://coreem.net/podcast/episode-219-meningitis-2-0/ We review diagnosing and managing bacterial meningitis in the ED. Hosts: Sarah Fetterolf, MD Avir Mitra, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Meningitis_2_0.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Meningitis_2_0.mp3) Leave a Comment (https://coreem.net/podcast/episode-219-meningitis-2-0/#comments) Tags: CNS Infections (https://coreem.net/tag/cns-infections/), Infectious Diseases (https://coreem.net/tag/infectious-diseases/), Neurology (https://coreem.net/tag/neurology/) Show Notes Core EM Modular CME Course Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights: - Credit: 12.5 AMA PRA Category 1 Credits™ - Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics. - Cost: - Free for NYU Learners - $250 for Non-NYU Learners Click Here to Register and Begin Module 1 (https://www.highmarksce.com/nyumc/Planners/viewActivity?style=2&preview=true&plannerID=3560#CourseDetails) Patient Presentation & Workup - Patient: 36-year-old male, currently shelter-domiciled, presenting with 3 weeks of generalized weakness, fevers, weight loss, and headaches. - Vitals (Initial): BP 147/98, HR 150s, Temp 100.2°F, RR 18, O2 99% RA. - Clinical Evolution: Initial assessment noted cachexia and a large ventral hernia. Following initial workup, the patient became acutely altered (A&O x0) and febrile to 102.9°F. - Physical Exam Findings: - Brudzinski Sign: Positive (knees flexed upward upon passive neck flexion). - Kernig Sign: Discussed as highly specific (resistance/pain during knee extension with hip flexed at 90°). - Meningeal Triad: Fever, nuchal rigidity, and AMS (present in 40% of cases; 95% of patients have at least two of the four cardinal symptoms including headache). - Imaging: - Chest X-ray: Scattered opacities (pneumonia) and a small pneumothorax. - CT Abdomen/Pelvis: Confirmed asplenia (secondary to 2011 GSW/exploratory laparotomy). - Head CT: Ventricle enlargement concerning for obstructive hydrocephalus and diffuse sulcal effacement. CSF Analysis & Microbiology - Bacterial Meningitis - Opening Pressure: Elevated (Normal is <170 mm H2O). - Color: Cloudy or turbid. - Gram Stain: Positive in 60%–80% of cases before antibiotics; drops to 7%–41% after antibiotics. - Cell Count: Very high (>1000–2000/mm3 WBC); dominated by neutrophils (>80% PMN). - Glucose: Low (<40 mg/dL); CSF/blood glucose ratio is <0.3–0.4. - Protein: High (>200 mg/dL). - Cytology: Negative. - Viral Meningitis - Opening Pressure: Normal. - Color: Clear or bloody. - Gram Stain: Negative. - Cell Count: Slightly elevated (<300/mm3 WBC); dominated by lymphocytes (<20% PMN). - Glucose: Normal. - Protein: Moderately elevated (<200 mg/dL). - Cytology: Negative. - Fungal Meningitis - Opening Pressure: Normal to elevated. - Color: Clear or cloudy. - Gram Stain: Negative. - Cell Count: Elevated (<500/mm3 WBC). - Glucose: Normal to slightly low. - Protein: High (>200 mg/dL). - Cytology: Negative. - Neoplastic (Cancer-related) Meningitis - Opening Pressure: Normal. - Color: Clear or cloudy. - Gram Stain: Negative. - Cell Count: Elevated (<300/mm3 WBC). - Glucose: Normal to slightly low. - Protein: High (>200 mg/dL). - Cytology: Positive (this is the key differentiator). Management Protocol - Immediate Treatment: Early administration of antibiotics/antivirals is critical to reduce mortality. - Antibiotics: Ceftriaxone 2g IV q12h + Vancomycin (or Rifampin in cephalosporin-resistant areas). - Listeria Coverage: Add Ampicillin for patients > 50 years old. - Antivirals: Acyclovir 10 mg/kg q8h. - Steroids: Dexamethasone 10 mg IV q6h for 4 days (proven…
Not rated yetEpisode 218: Sympathetic Crashing Acute Pulmonary Edema (SCAPE)
· 12 min
https://coreem.net/podcast/episode-218-sympathetic-crashing-acute-pulmonary-edema-scape/ We discuss the diagnosis and management of SCAPE in the ED. Hosts: Naz Sarpoulaki, MD, MPH Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/SCAPEv2.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/SCAPEv2.mp3) Leave a Comment (https://coreem.net/podcast/episode-218-sympathetic-crashing-acute-pulmonary-edema-scape/#comments) Tags: Acute Pulmonary Edema (https://coreem.net/tag/acute-pulmonary-edema/), Critical Care (https://coreem.net/tag/critical-care/) Show Notes Core EM Modular CME Course Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights: - Credit: 12.5 AMA PRA Category 1 Credits™ - Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics. - Cost: - Free for NYU Learners - $250 for Non-NYU Learners Click Here to Register and Begin Module 1 (https://www.highmarksce.com/nyumc/Planners/viewActivity?style=2&preview=true&plannerID=3560#CourseDetails) The Clinical Case - Presentation: 60-year-old male with a history of HTN and asthma. - EMS Findings: Severe respiratory distress, SpO₂ in the 60s on NRB, HR 120, BP 230/180. - Exam: Diaphoretic, diffuse crackles, warm extremities, pitting edema, and significant fatigue/work of breathing. - Pre-hospital meds: NRB, Duonebs, Dexamethasone, and IM Epinephrine (under the assumption of severe asthma/anaphylaxis). Differential Diagnosis for the Hypoxic/Tachypneic Patient - Pulmonary: Asthma/COPD, Pneumonia, ARDS, PE, Pneumothorax, Pulmonary Edema, ILD, Anaphylaxis. - Cardiac: CHF, ACS, Tamponade. - Systemic: Anemia, Acidosis. - Neuro: Neuromuscular weakness. What is SCAPE? Sympathetic Crashing Acute Pulmonary Edema (SCAPE) is characterized by a sudden, massive sympathetic surge leading to intense vasoconstriction and a precipitous rise in afterload. - Pathophysiology: Unlike HFrEF, these patients are often euvolemic or even hypovolemic. The primary issue is fluid maldistribution (fluid shifting from the vasculature into the lungs) due to extreme afterload. Bedside Diagnosis: POCUS vs. CXR POCUS is the gold standard for rapid bedside diagnosis. - Lung Ultrasound: Look for diffuse B-lines (≥3 in ≥2 bilateral zones). - Cardiac: Assess LV function and check for pericardial effusion. - Why not CXR? A meta-analysis shows LUS has a sensitivity of ~88% and specificity of ~90%, whereas CXR sensitivity is only ~73%. Importantly, up to 20% of patients with decompensated HF will have a normal CXR. Management Strategy 1. NIPPV (CPAP or BiPAP) Start NIPPV immediately to reduce preload/afterload and recruit alveoli. - Settings: CPAP 5–8 cm H₂O or BiPAP 10/5 cm H₂O. Escalate EPAP quickly but keep pressures to avoid gastric insufflation. - Evidence: NIPPV reduces mortality (NNT 17) and intubation rates (NNT 13). 2. High-Dose Nitroglycerin The goal is to drop SBP to < 140–160 mmHg within minutes. - No IV Access: 3–5 SL tabs (0.4 mg each) simultaneously. - IV Bolus: 500–1000 mcg over 2 minutes. - IV Infusion: Start at 100–200 mcg/min; titrate up rapidly (doses > 800 mcg/min may be required). - Safety: ACEP policy supports high-dose NTG as both safe and effective for hypertensive HF. Use a dedicated line/short tubing to prevent adsorption issues. 3. Refractory Hypertension If SBP remains > 160 mmHg despite NIPPV and aggressive NTG, add a second vasodilator: - Clevidipine: Ultra-short-acting calcium channel blocker (titratable and rapid). - Nicardipine: Effective alternative for rapid BP control. - Enalaprilat: Consider if the above are unavailable. Troubleshooting & Pitfalls The “Mask Intolerant” Patient Hypoxia is the primary driver of agitation.…
Not rated yetEpisode 217: Prehospital Blood Transfusion
https://coreem.net/podcast/episode-217-prehospital-blood-transfusion/ We discuss the shift to prehospital blood to treat shock sooner. Hosts: Nichole Bosson, MD, MPH, FACEP Avir Mitra, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Prehospital_Transfusion.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Prehospital_Transfusion.mp3) Leave a Comment (https://coreem.net/podcast/episode-217-prehospital-blood-transfusion/#comments) Tags: EMS (https://coreem.net/tag/ems/), Prehospital Care (https://coreem.net/tag/prehospital-care/), Trauma (https://coreem.net/tag/trauma/) Show Notes Core EM Modular CME Course Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights: - Credit: 12.5 AMA PRA Category 1 Credits™ - Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics. - Cost: - Free for NYU Learners - $250 for Non-NYU Learners Click Here to Register and Begin Module 1 (https://www.highmarksce.com/nyumc/Planners/viewActivity?style=2&preview=true&plannerID=3560#CourseDetails) What is prehospital blood transfusion - Administration of blood products in the field prior to hospital arrival - Aimed at patients in hemorrhagic shock Why this matters - Traditional US prehospital resuscitation relied on crystalloid - ED and trauma care now prioritize early blood - Hemorrhage occurs before hospital arrival - Delays to definitive hemorrhage control are common - Earlier blood may improve survival Supporting rationale - ATLS and trauma paradigms emphasize blood over fluid - National organizations support prehospital blood when feasible - EMS already manages high risk, time sensitive interventions Evidence overview - Data are mixed and evolving - COMBAT: no benefit - PAMPer: mortality benefit - RePHILL: no clear benefit - Signal toward benefit when transport time exceeds ~20 minutes - Urban systems still experience long delays due to traffic and geography - LA County median time to in hospital transfusion ~35 minutes LA County program - ~2 years of planning before launch - Pilot began April 1 - Partnerships: - LA County Fire - Compton Fire - Local trauma centers - San Diego Blood Bank - 14 units of blood circulating in the field - Blood rotated back 14 days before expiration - Ultimately used at Harbor UCLA - Continuous temperature and safety monitoring Indications used in LA County - Focused rollout - Trauma related hemorrhagic shock - Postpartum hemorrhage Physiologic criteria: - SBP < 70 - Or HR > 110 with SBP < 90 - Shock index ≥ 1.2 - Witnessed traumatic cardiac arrest Products: - One unit whole blood preferred - Two units PRBCs if whole blood unavailable Early experience - ~28 patients transfused at time of discussion - Evaluating: - Indications - Protocol adherence - Time to transfusion - Early outcomes - Too early for outcome conclusions California collaboration - Multiple active programs: - Riverside (Corona Fire) - LA County - Ventura County - Additional programs planned: - Sacramento - San Bernardino - Programs meet monthly as CalDROP - Focus on shared learning and operational optimization Barriers and concerns - Trauma surgeon concerns about blood supply - Need for system wide buy in - Community engagement - Patients who may decline transfusion - Women of childbearing age and alloimmunization risk - Risk of HDFN is extremely low - Clear communication with receiving hospitals is essential Future direction - Rapid national expansion expected - Greatest benefit likely where transport delays exist - Prehospital Blood Transfusion Coalition active nationally - Major unresolved issue: reimbursement - Currently funded largely by fire departments -…
Not rated yetEpisode 216: BRUE (Brief Resolved Unexplained Event)
https://coreem.net/podcast/episode-216-brue-brief-resolved-unexplained-event/ We review BRUEs (Brief Resolved Unexplained Events). Hosts: Ellen Duncan, MD, PhD Noumi Chowdhury, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/BRUE.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/BRUE.mp3) Leave a Comment (https://coreem.net/podcast/episode-216-brue-brief-resolved-unexplained-event/#comments) Tags: Pediatrics (https://coreem.net/tag/pediatrics/) Show Notes What is a BRUE? - BRUE stands for Brief Resolved Unexplained Event. - It typically affects infants <1 year of age and is characterized by a sudden, brief, and now resolved episode of one or more of the following: - Cyanosis or pallor - Irregular, absent, or decreased breathing - Marked change in tone (hypertonia or hypotonia) - Altered level of responsiveness Crucial Caveat: BRUE is a diagnosis of exclusion. If the history and physical exam reveal a specific cause (e.g., reflux, seizure, infection), it is not a BRUE. Risk Stratification: Low Risk vs. High Risk Risk stratification is the most important step in management. While only 6-15% of cases meet strict “Low Risk” criteria, identifying these patients allows us to avoid unnecessary invasive testing. Low Risk Criteria To be considered Low Risk, the infant must meet ALL of the following: - Age: > 60 days old - Gestational Age: GA > 32 weeks (and Post-Conceptional Age > 45 weeks) - Frequency: This is the first episode - Duration: Lasted < 1 minute - Intervention: No CPR performed by a trained professional - Clinical Picture: Reassuring history and physical exam Management for Low Risk: - Generally do not require extensive testing or admission. - Prioritize safety education/anticipatory guidance. - Ensure strict return precautions and close outpatient follow-up (within 24 hours). High Risk Criteria Any infant not meeting the low-risk criteria is automatically High Risk. Additional red flags include: - Suspicion of child abuse - History of toxin exposure - Family history of sudden cardiac death - Abnormal physical exam findings (trauma, neuro deficits) Management for High Risk: - Requires a more thorough evaluation. - Often requires hospital admission. - Note: Serious underlying conditions are identified in approx. 4% of high-risk infants. Differential Diagnosis: “THE MISFITS” Mnemonic - T – Trauma (Accidental or Non-accidental/Abuse) - H – Heart (Congenital heart disease, dysrhythmias) - E – Endocrine - M – Metabolic (Inborn errors of metabolism) - I – Infection (Sepsis, meningitis, pertussis, RSV) - S – Seizures - F – Formula (Reflux, allergy, aspiration) - I – Intestinal Catastrophes (Volvulus, intussusception) - T – Toxins (Medications, home exposures) - S – Sepsis (Systemic infection) Workup & Diagnostics Step 1: Stabilization - ABCs (Airway, Breathing, Circulation) - Point-of-care Glucose - Cardiorespiratory monitoring Step 2: Diagnostic Testing (For High Risk/Symptomatic Patients) - Labs: VBG, CBC, Electrolytes. - Imaging: - CXR: Evaluate for infection and cardiothymic silhouette. - EKG: Evaluate for QT prolongation or dysrhythmias. - Neuro: Consider Head CT/MRI and EEG if there are concerns for trauma or seizures. Clinical Pearl: Only ~6% of diagnostic tests contribute meaningfully to the diagnosis. Be judicious—avoid “shotgunning” tests in low-risk patients. Prognosis & Outcomes - Recurrence: Approximately 10% (lower than historical ALTE rates of 10-25%). - Mortality: < 1%. Nearly always linked to an identifiable cause (abuse, metabolic disorder, severe infection). - BRUE vs. SIDS: These are not the same. - BRUE: Peaks < 2 months; occurs mostly during the day. - SIDS: Peaks 2–4 months; occurs mostly midnight to 6:00 AM. Take-Home Points - Diagnosis of Exclusion: You cannot call it a BRUE until you have ruled out obvious causes via history and physical. - Strict Criteria: Stick strictly to the Low Risk…
Not rated yetEpisode 215: Marburg Virus and Global EM
https://coreem.net/podcast/episode-215-marburg-virus-and-global-em/ Lessons from Rwanda’s Marburg Virus Outbreak and Building Resilient Systems in Global EM. Hosts: Tsion Firew, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Marburg_Virus.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Marburg_Virus.mp3) Leave a Comment (https://coreem.net/podcast/episode-215-marburg-virus-and-global-em/#comments) Tags: Global Health (https://coreem.net/tag/global-health/), Infectious Diseases (https://coreem.net/tag/infectious-diseases/) Show Notes Context and the Rwanda Marburg Experience - The Threat: Marburg Virus Disease is from the same family as Ebola and has historically had a reported fatality rate as high as 90%. - The Outbreak (Sept. 2024): Rwanda declared an MVD outbreak. The initial cases involved a miner, his pregnant wife (who fell ill and died after having a baby), and the baby (who also died). - Healthcare Worker Impact: The wife was treated at an epicenter hospital. Eight HCWs were exposed to a nurse who was coding in the ICU; all eight developed symptoms, tested positive within a week, and four of them died. - The Turning Point: The outbreak happened in city referral hospitals where advanced medical interventions (dialysis, mechanical ventilation) were available. - Rapid Therapeutics Access: Within 10 days of identifying Marburg, novel therapies (experimental drugs and monoclonal antibodies) and an experimental vaccine were made available through diplomacy with the US government/CDC and agencies like WHO, Africa CDC, CEPI and more. - The Outcome: This coordinated effort—combining therapeutics, widespread testing, and years of investment in a resilient healthcare system—helped curb the fatality rate down to 23%. Barriers and Enablers in Outbreak Preparedness - Fragmented Systems: Emergency and surveillance functions often operate in silos, leading to delayed or missed outbreak identification (e.g., inconsistent travel screening at JFK during early COVID-19 vs. African countries). - Solution: Empowering Emergency Departments and the community as the sentinel site can bridge this gap. - Limited Frontline Capacity and Protection: Clinicians are often undertrained and underprotected and are frequently not part of the decision-making for surveillance. - Weak Governance and Accountability: Unclear command structures and lack of feedback discourage early reporting. - Enabler: Strong governance and accountability in Rwanda helped contain the virus. - Dependence on External Programs: Many low-income countries rely on outside sources for vaccines and therapeutics, slowing response. - Solution: Invest in local production (e.g., Rwanda’s pre-outbreak investment in developing its own mRNA vaccines). - Lack of Resource-Smart Innovation: Gaps exist in things like integrating digital triage tools and surveillance systems. Four Pillars of a Responsive and Equitable Emergency System - Workforce: Invest in pre-service and in-service training, mentorship, and fair compensation to ensure a skilled, protected, and motivated team. - Integration into the Health System: Emergency care (including pre-hospital services) must not operate in silos; it needs to be embedded in national health strategies and linked to surveillance, referral, and financing systems. - Equity in Design and Policy: The system must address the needs and protection of vulnerable groups and work closely with policymakers. - Data: Utilize real-time data and dashboards to provide a feedback loop between clinicians and policymakers, enabling tailored and innovative interventions. Advice for Clinicians in Global Health Work - Start Small and Build Trust: Meaningful work requires humility and relationship over scale or visibility. Focus on local priorities and sustainable change through long-term partnership, not just presence. Avoid the “savior mindset”. - Be T-Shaped: Be deep in one…
Not rated yetEpisode 214: Acute Pulmonary Embolism
https://coreem.net/podcast/episode-214-acute-pulmonary-embolism/ We review the diagnosis, risk stratification, & management of acute pulmonary embolism in the ED. Hosts: Vivian Chiu, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Acute_Pulmonary_Embolism.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Acute_Pulmonary_Embolism.mp3) One Comment (https://coreem.net/podcast/episode-214-acute-pulmonary-embolism/#comments) Tags: Pulmonary (https://coreem.net/tag/pulmonary/) Show Notes Core Concepts and Initial Approach - Definition: Obstruction of pulmonary arteries, usually from a DVT in the proximal lower extremity veins (iliac/femoral), but may be tumor, air, or fat emboli. - Incidence & Mortality: 300,000–370,000 cases/year in the USA, with 60,000–100,000 deaths annually. - Mantra: “Don’t anchor on the obvious. Always risk stratify and resuscitate with precision.” - Risk Factors: Broad, including older age, inherited thrombophilias, malignancy, recent surgery/trauma, travel, smoking, hormonal use, and pregnancy. Clinical Presentation and Risk Stratification - Presentation: Highly variable, showing up as anything from subtle shortness of breath to collapse. - Acute/Subacute: Dyspnea (most common), pleuritic chest pain, cough, hemoptysis, and syncope. Patients are likely tachycardic, tachypneic, hypoxemic on room air, and may have a low-grade fever. - Chronic: Can mimic acute symptoms or be totally asymptomatic. - Pulmonary Infarction Signs: Pleuritic pain, hemoptysis, and an effusion. - High-Risk Red Flags: Signs of hypotension (systolic blood pressure < 90 mmHg for over 15 minutes), requirement of vasopressors, or signs of shock → activate PERT team immediately. - Crucial Mimics: Think broadly; consider pneumonia, ACS, pneumothorax, heart failure exacerbation, and aortic dissection. Workup & Diagnostics - History/Scoring: Ask about prior clots, recent surgeries, hospitalizations, travel. Use Wells/PERC criteria to assess pretest probability. - Labs: - D-dimer: A good test to rule out PE in a patient with low probability. If suspicion is high, proceed directly to imaging. - Troponin/BNP: Act as RV stress gauges. Elevated levels are associated with increased risk of a complicated clinical course (25-40%). - Lactate: Helpful in identifying patients in possible cardiogenic shock. - EKG: Most common finding is sinus tachycardia. Classic RV strain patterns (S1Q3T3, T-wave changes/inversions) are nonspecific. - Imaging: - CXR: Usually normal, but quick and essential to rule out other causes. - CTPA: The usual standard and gold standard for stable patients. High sensitivity (> 95%) and can detect RV enlargement/strain. - V/Q Scan: Option for patients with contraindications to contrast (e.g., severe contrast allergies). - POCUS (Point-of-Care Ultrasound): Useful adjunct for unstable patients. - Bedside Echo: Can show signs of RV strain (enlarged RV, McConnell sign). - Lower Extremity Ultrasound: Can identify a DVT in proximal leg veins. Treatment & Management - Resuscitation (Reviving the RV): - Oxygenation: Give supplementally as needed (nasal cannula, non-rebreather, high flow). - Intubation: Avoid if possible; positive pressure ventilation can worsen RV dysfunction. - Fluids: Be judicious; even the smallest amount can worsen RV overload. - Vasopressors: Norepinephrine is preferred as first-line for hypotension/shock. - Anticoagulation (Start Immediately): - Initial choice is UFH or LMWH (Lovenox). - Lovenox is preferred for quicker time to therapeutic range, but is contraindicated in renal dysfunction, older age, or need for emergent procedures. - DOACs can be considered for stable, low-risk patients as an outpatient. Escalation for High-Risk PE - Systemic Thrombolytics: Consider for very sick patients with shock/cardiac arrest (e.g., Alteplase 100 mg over two hours or a bolus in cardiac arrest). High risk of intracranial…
Not rated yetEpisode 213: Pneumothorax
https://coreem.net/podcast/episode-213-pneumothorax/ We break down pneumothorax: risks, diagnosis, and management pearls. Hosts: Christopher Pham, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Pneumothorax.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Pneumothorax.mp3) Leave a Comment (https://coreem.net/podcast/episode-213-pneumothorax/#comments) Tags: Chest Trauma (https://coreem.net/tag/chest-trauma/), Pulmonary (https://coreem.net/tag/pulmonary/), Trauma (https://coreem.net/tag/trauma/) Show Notes Risk Factors for Pneumothorax - Secondary pneumothorax - Trauma: rib fractures, blunt chest trauma (as in the case). - Iatrogenic: central line placement, thoracentesis, pleural procedures. - Primary spontaneous pneumothorax - Young, tall, thin males (10–30 years). - Connective tissue disorders: Marfan, Ehlers-Danlos. - Underlying lung disease: COPD with bullae, interstitial lung disease, CF, TB, malignancy. - Technically, anyone is at risk. Symptoms & Differential Diagnosis - Typical PTX presentation: Dyspnea, chest pain, pleuritic discomfort. - Exam clues: unilateral decreased breath sounds, focal tenderness/crepitus. - Red flags (suggest tension PTX): - JVD - Tracheal deviation - Hypotension, shock physiology - Severe tachycardia, hypoxia - Differential diagnoses: - Pulmonary: asthma, COPD, pneumonia, pulmonary edema (SCAPE), ILD, infections. - Cardiac: ACS, CHF, pericarditis. - PE and other acute causes of dyspnea. Diagnostics - Bloodwork: limited role, except type & screen if intervention likely. - EKG: reasonable given chest pain/shortness of breath. - Imaging: - POCUS (bedside ultrasound) - High sensitivity (86–96%) & specificity (97–100%). - Signs: - Seashore sign: normal lung sliding. - Barcode sign: absent lung sliding. - Lung point: most specific for PTX. - CXR - Sensitivity ~70–90% for small PTX. - May show pleural line, hyperlucency. - CT chest (gold standard) - Defines size/severity. - Rules out mimics (bullae, pleural effusion, hemothorax). - Guides intervention choice. Management - First step for all: Oxygen supplementation (non-rebreather if possible). - Accelerates resorption of pleural air. - Stable vs. unstable decision point: - Unstable/tension PTX - Immediate needle thoracostomy (14-g angiocath, 2nd ICS midclavicular). - Temporizing until chest tube/pigtail placed. - Stable, small PTX (<2 cm on O₂) - Observation, supplemental O₂, conservative management. - Stable, larger PTX or symptomatic - Chest tube or pigtail catheter insertion. - Pigtail catheters: less invasive, more comfortable, similar efficacy for simple PTX. - Large bore tubes: indicated if associated with blood, pus, large collections. Disposition - Admit all patients with chest tubes; cannot be discharged with tube in place. - Service responsible varies by hospital: trauma, CT surgery, MICU, etc. - Level of care (ICU vs. floor) depends on stability: - ICU if unstable course, intubated, shock physiology. - Stepdown/floor if stable and straightforward. Take Home Points - Always broaden differential in dyspnea/chest pain → don’t anchor on asthma/COPD. - Exam findings + history (trauma, risk factors) crucial to raising suspicion. - Ultrasound is more sensitive than CXR and highly specific when lung point found. - Oxygen is first-line; intervention determined by size + stability. - Pigtail catheters increasingly favored for simple, stable PTX. - All patients with intervention require admission; service varies by institution. Read More (https://coreem.net/podcast/episode-213-pneumothorax/)
Not rated yetEpisode 212: Angioedema
https://coreem.net/podcast/episode-212-angioedema/ Angioedema – Recognition and Management in the ED Hosts: Maria Mulligan-Buckmiller, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Angioedema.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Angioedema.mp3) Leave a Comment (https://coreem.net/podcast/episode-212-angioedema/#comments) Tags: Airway (https://coreem.net/tag/airway/) Show Notes Definition & Pathophysiology Angioedema = localized swelling of mucous membranes and subcutaneous tissues due to increased vascular permeability. Triggers increased vascular permeability → fluid shifts into tissues. Etiologies - Histamine-mediated (anaphylaxis) - Associated with urticaria/hives, pruritus, and redness. - Triggered by allergens (foods, insect stings, medications). - Rapid onset (minutes to hours). - Bradykinin-mediated - Hereditary angioedema (HAE): C1 esterase inhibitor deficiency (autosomal dominant). - Acquired angioedema: Associated with B-cell lymphoma, autoimmune disease, MGUS. - Medication-induced: Most commonly ACE inhibitors; rarely ARBs. - Typically lacks urticaria and itching. - Gradual onset, can last days if untreated. - Idiopathic angioedema - Unknown cause; diagnosis of exclusion. Clinical Presentations - Swelling - Asymmetric, non-pitting, usually non-painful. - May involve lips, tongue, face, extremities, GI tract. - Respiratory compromise - Upper airway swelling → stridor, dyspnea, sensation of throat closure. - Airway obstruction is the most feared complication. - Abdominal manifestations - Bowel wall angioedema can mimic acute abdomen: - Nausea, vomiting, diarrhea, severe pain, increased intra-abdominal pressure, possible ischemia. Key Differentiating Features - Histamine-mediated: rapid onset, hives/itching, resolves quickly with epinephrine, antihistamines, and steroids. - Bradykinin-mediated: slower onset, lacks urticaria, prolonged duration, less responsive to standard anaphylaxis medications. Diagnostic Approach in the ED - Focus on airway (ABCs) and clinical assessment. - Labs (e.g., C4 level) useful for downstream diagnosis (esp. HAE) but not for acute management. - Imaging: only if symptoms suggest abdominal involvement or to rule out other causes. Treatment Strategies - Airway protection is always priority: - Early consideration of intubation if worsening obstruction or inability to manage secretions. - Histamine-mediated (anaphylaxis): - Epinephrine (IM), antihistamines, corticosteroids. - Bradykinin-mediated: - Epinephrine may be tried if unclear etiology (no significant harm, lifesaving if histamine-mediated). - Targeted therapies: - Icatibant: bradykinin receptor antagonist. - Ecallantide: kallikrein inhibitor (less available). - C1 esterase inhibitor concentrate: replenishes deficient protein. - Fresh frozen plasma (FFP): contains C1 esterase inhibitor. - Tranexamic acid (TXA): off-label, less evidence, considered if no other options. Complications to Watch For - Airway compromise: rapid deterioration possible. - Abdominal compartment syndrome from bowel edema (rare, surgical emergency). Take-Home Points - Secure the airway if in doubt. - Differentiate histamine-mediated vs bradykinin-mediated by presence/absence of hives/itching and speed of onset. - Use epinephrine promptly if suspecting histamine-mediated angioedema or if uncertain. - Consider bradykinin-targeted therapies for confirmed hereditary, acquired, or ACE-inhibitor–related angioedema. - Recognize ACE inhibitors as the most frequent medication trigger; ARBs rarely cause it. - Labs and imaging generally don’t change initial ED management but aid diagnosis for follow-up care. Read More (https://coreem.net/podcast/episode-212-angioedema/)
Not rated yetEpisode 211: Granulomatosis with Polyangiitis
https://coreem.net/podcast/episode-211-granulomatosis-with-polyangiitis/ Granulomatosis with Polyangiitis (GPA) – Recognition and Management in the ED Hosts: Phoebe Draper, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/GPA.mp3 Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/GPA.mp3) One Comment (https://coreem.net/podcast/episode-211-granulomatosis-with-polyangiitis/#comments) Tags: Rheumatology (https://coreem.net/tag/rheumatology/) Show Notes Background - A vasculitis affecting small blood vessels causing inflammation and necrosis - Affects upper respiratory tract (sinusitis, otitis media, saddle nose deformity), lungs (nodules, alveolar hemorrhage), and kidneys (rapidly progressive glomerulonephritis) - Can lead to multi-organ failure, pulmonary hemorrhage, renal failure Red Flag Symptoms: - Chronic sinus symptoms - Hemoptysis (especially bright red blood) - New pulmonary complaints - Renal dysfunction - Constitutional symptoms (fatigue, weight loss, fever) Workup in the ED: - CBC, CMP for anemia and AKI - Urinalysis with microscopy (hematuria, RBC casts) - Chest imaging (CXR or CT for nodules, cavitary lesions) - ANCA testing (not immediately available but important diagnostically) Management: - Stable patients: Outpatient workup, urgent rheumatology consult, prednisone 1 mg/kg/day - Unstable patients: High-dose IV steroids (methylprednisolone 1 g daily x3 days), consider plasma exchange, cyclophosphamide or rituximab initiation, ICU admission Conditions that Mimic GPA: - Goodpasture syndrome (anti-GBM antibodies) - TB, fungal infections - Lung malignancy - Other vasculitides (EGPA, MPA, lupus) ANCA Testing Utility: - C-ANCA/PR3-ANCA positive in 80-90% of GPA cases - P-ANCA/MPO-ANCA more common in MPA - Don’t delay treatment while awaiting results if suspicion is high Outcomes: - Without treatment: Fatal within a year (renal failure, respiratory complications) - With treatment: 5-year survival ~75-90%, but ~50% relapse rate - Long-term rheumatology follow-up is essential Take-Home Points: - Always include vasculitis in the differential for unexplained respiratory, renal, or systemic symptoms. - Recognize pulmonary-renal syndromes early. - Initiate high-dose steroids immediately for unstable patients without waiting for ANCA results. - GPA is rare but life-threatening – early recognition saves lives. Read More (https://coreem.net/podcast/episode-211-granulomatosis-with-polyangiitis/)
Not rated yet